Address	Kjelsasveien 168 B Oslo PS 0884 Norway
Employees	-
Website	http://www.nordicnanovector.com
Updated	07/08/2019
Nordic Nanovector ASA engages in the provision of development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers such as non-Hodgkin's Lymphoma and leukaemia. It offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. Nordic Nanovector operates its business through the following geographical segments: Norway, Switzerland, and the United Kingdom.